Immunomedics Announces Preclinical Results Of Milatuzumab

Reader Comments (0)

December 9, 2009 (FinancialWire) — Immunomedics, Inc. (NASDAQ: IMMU) announced results from 3 preclinical studies aimed at understanding the mechanism of action of its proprietary humanized anti-CD74 antibody, milatuzumab, which is currently in clinical development for multiple myeloma, non-Hodgkin’s lymphoma and chronic lymphocytic leukemia .

The first study was on…

The content you are accessing is available to FinancialWire™ subscribers. We invite you to subscribe today, by selecting any of these special, introductory subscription packages:


New Site Visitors -- One week free trial, with the option to continue at the introductory rates listed here. Fee: Free   Three Months -- Complete access to all FinancialWire™ articles (past, present and future) for the next three months. Fee: $9.00
 
Today Only -- The option to access any day's FinancialWire™ edition is always available. Fee: $1.00   Six Months -- Complete access to all FinancialWire™ articles (past, present and future) for the next six months. Fee: $12.00
 
One Month -- Complete access to all FinancialWire™ articles (past, present and future) for the next month. Fee: $5.00   One Year -- Complete access to all FinancialWire™ articles (past, present and future) for the next year. Fee: $18.00

Front Page news from all FinancialWire™ editions is always available free of charge. Just select from the "Previous Issues" menu (at the upper-right of this page).


You must be logged in to purchase a subscription. If you do not have a FinancialWire™ account, it is free to register.


Please Note: You will not be automatically billed for any renewals. When your subscription expires, you will simply no longer be able to access all FinancialWire™ content until you renew your expired subscription.

After completing this subscription order, you will have the opportunity to review all your subscriber details before confirming your subscription.

FinancialWire™'s Privacy Policy: We will keep any personal/contact information provided to us completely confidential, and will not share any such information with anyone else. In addition, we will not contact you for any reason, unless you specifically request for us to do so.

Comments

Post a Comment

You must be logged in to post a comment. If you do not have a FinancialWire™ Reader Comments account, it is free to register.



Additional Headlines
Immunomedics Updates Veltuzumab Results Immunomedics Announces Preclinical Results Of Milatuzumab
Compuware Simplifies IT Portfolio Management With New Enhancements TransAct Printer Selected By Resorts World In Singapore
OTI Subsidiary Expands EasyPark Vitesse Expands Deployment Of Magma’s Talus 1.1 Digital Implementation System
JBI CEO Reduces Outstanding Common Shares By 12 Million Massachusetts Bar Association’s Information Security Summit To Showcase Data Privacy
Cabot Microelectronics Earns Supplier Award Nalco Increases Investment In China
SoundBite Communications Announces Multi-Channel Customer Communications Platform Compuware Launches New Initiative To Increase Profitability
California Wastewater Treatment Facility Expands FuelCell Energy Power Plant Neah Power Fuel Cell Chargers Deliver Renewable Back-Up Power
Omnitek Engineering Signs MOI With Phillipine Bio-Energy Company Plateau Mineral Development Appoints William Strange President
Hydrogenics Commissions Eleventh Fuel Cell Midibus For European Market Energy XXI Presenting At Energy Conference
Comverge Closes Over-Allotment Option Mariner’s Choice Expands To Major Auto Parts Distributor
Banner Commences $75 Million Common Stock Public Offering Bridge Bancorp Completes Trust Preferred Offering
First Horizon National Presenting Goldman Sachs U.S. Financial Services Conference Triangle Capital Commences Public Common Stock Offering
Roper Industries Buys Verathon MasterCard Declares Dividend
MDC Partners To Buy Communifx Nova Measuring Instruments Files $20 Million Mixed Shelf
Simon Property Group To Buy Prime Outlets McDonald Named P&G Chairman
Alliant Techsystems Wins $5.8 Million Navy Contract Hughes Unit Wins New York Telecom Contract
CECO Environmental Receives $8.5 Million Of Orders National Technical Systems Buys Bureau Veritas Unit
James Named To Applied Materials Board Bertolini Named To Genzyme Board
Laybourne Named To JCPenney Board Quinn Named Information Chief At Paccar
Acuity Brands Sells $350 Million Of Senior Notes Packaging Corp. Declares Dividend
ValuEngine Upgrades Gafisa SA, Waddell & Reed Financial, Stec, Plains Exploration & Production, Canadian Natural Resources Conference Calls Today: 8-8:20 A.M. EDT
Conference Calls Today: 8:30 A.M. EDT Conference Calls Today: 9-9:30 A.M. EDT
Conference Calls Today: 10 A.M. EDT Conference Calls Today: 11-3:30 A.M. EDT
Conference Calls Today: 4-4:30 P.M. EDT Conference Calls Today: 5 P.M. EDT
Conference Calls Today: 6-7 P.M. EDT Hercules Offshore Names Bates As Chairman
Voyager, Cambium Complete Merger Greif Declares Common Share Dividends
FirstAlert(tm) Daily 12/9: Real New Fear Is Higher Taxes New Rally High For FedEx,Says Market Timer Frank Kollar
Dissinger Named CFO Of Kellogg Danaher Declares Dividend
PepsiCo, Dr. Pepper Snapple Ink Distribute Deal WD-40 Declares Dividend, Authorizes Buyback
Mack-Cali Realty Declares Dividends McDonough Named CMO At Diageo North America
Uveges To Replace Little As Microfluidics Chairman